Evidence map›Paper›PMID 16292892›Full record

ArticleTechnology in cancer research & treatment2005

The comet assay to determine the mode of cell death for the ultrasonic delivery of doxorubicin to human leukemia (HL-60 Cells) from Pluronic P105 micelles.

Ghaleb A Husseini, Kim L O'Neill, William G Pitt

Abstract read
In one paragraph

Article in Technology in cancer research & treatment, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Programmed cell death detection methods: a systematic review and a categorical comparison.Apoptosis : an international journal on programmed cell death · 2022
    Pooled it
  2. Article
  3. Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review.ACS pharmacology & translational science · 2021
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. The use of ultrasound and micelles in cancer treatment.Journal of nanoscience and nanotechnology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ghaleb A HusseiniDepartment of Chemical Engineering, American University of Sharjah, United Arab Emirates. ghusseini@ausharjah.edu
Kim L O'Neill
William G Pitt

Funding

Controlled Drug Delivery to Colon Tumors Via UltrasoundR01CA098138 · NCI · BRIGHAM YOUNG UNIVERSITY · PI PITT, WILLIAM G · 2004 to 2006
$713k
NCI NIH HHS R01 CA098138
6 · The paper itself

Abstract

This notes examines the mode of cell death of HL-60 cells exposed to 70 kHz and 1.3 W/cm(2) ultrasound in the presence of 1% Pluronic P105 and 1.67 microg/ml doxorubicin (Dox). The cells were ultrasonicated for 30, 60, and 120 minutes. They were then lysed, electrophorised, stained using propidium iodide, and their DNA profile captured using a fluorescent microscope. The gradual DNA damage observed and the comet tails captured after one and two hours of insonation suggest that the mode of cell killing is apoptosis.

Indexed as

Comet AssayUltrasonic TherapyAntibiotics, AntineoplasticApoptosisDNA DamageDNA, NeoplasmDose-Response Relationship, DrugDoxorubicinDrug Delivery SystemsHL-60 CellsHumansMicellesPoloxamerAntibiotics, AntineoplasticDNA, NeoplasmDoxorubicinMicellesPoloxamer

Identifiers

PMID16292892
PMCPMC1363380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.